Xcoo is an techonlogy company that provides software-as-a-solution services for precision medicine in oncology and rare disease.
Xcoo has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Xcoo's investors include SPARX Group.
Xcoo is headquartered in Tokyo, Japan.
Xcoo is an techonlogy company that provides software-as-a-solution services for precision medicine in oncology and rare disease.
Xcoo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xcoo — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/xcoo. Accessed August 14, 2026.
VCBacked. (2022). Xcoo — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xcoo
{{cite web |title=Xcoo — Funding & Investors |url=https://www.vcbacked.co/company/xcoo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated